RecruitingPhase 1 / Phase 2NCT04868604
64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)
Sponsor: Clarity Pharmaceuticals Ltd
River Ridge, LA · +6 more sites